Ibotenic acid and thioibotenic acid: a remarkable difference in activity at group III metabotropic glutamate receptors
Research output: Contribution to journal › Journal article › Research › peer-review
In this study, we have determined and compared the pharmacological profiles of ibotenic acid and its isothiazole analogue thioibotenic acid at native rat ionotropic glutamate (iGlu) receptors and at recombinant rat metabotropic glutamate (mGlu) receptors expressed in mammalian cell lines. Thioibotenic acid has a distinct pharmacological profile at group III mGlu receptors compared with the closely structurally related ibotenic acid; the former is a potent (low microm) agonist, whereas the latter is inactive. By comparing the conformational energy profiles of ibotenic and thioibotenic acid with the conformations preferred by the ligands upon docking to mGlu1 and models of the other mGlu subtypes, we propose that unlike other subtypes, group III mGlu receptor binding sites require a ligand conformation at an energy level which is prohibitively expensive for ibotenic acid, but not for thioibotenic acid. These studies demonstrate how subtle differences in chemical structures can result in profound differences in pharmacological activity.
|Journal||European Journal of Pharmacology|
|Publication status||Published - 23 Feb 2004|
- Animals, CHO Cells, Cricetinae, Cricetulus, Excitatory Amino Acid Agonists, Ibotenic Acid, Ligands, Male, Mice, Models, Molecular, Molecular Conformation, Radioligand Assay, Rats, Receptors, Metabotropic Glutamate, Thiazoles